|
|
Article: Biotech Holdings signs Sucanon Marketing agreement for Mexico.
- Article from:
- PR Newswire
- Article date:
- June 1, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Robert Rieveley, President of Biotech Holdings (the "Company", TSX-V: BIO.V; OTC BB: BIOHF) announced today that the Company has signed an agreement for marketing its Sucanon diabetes drug in Mexico.
"I am pleased to report that our marketing agreement for Mexico has now been signed. Pursuant to the agreement, we will be conducting an intensive campaign, beginning this month, to bring Sucanon to doctors, pharmacists and the public in Mexico," Mr. Rieveley said.
"We will be conducting symposia for doctors, providing Sucanon samples and carrying out an extensive program of doctor visits. We anticipate visiting eighteen hundred doctors in their offices ...